The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Preclinical safety evaluation of biotechnology-derived pharmaceuticals
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nicholson, J. K., Lindon, J. C., & Holmes, E. (1999) · Xenobiotica · doi:10.1080/004982599238047 · Cited by 3,895
Botkin, J. R., Belmont, J. W., Berg, J. S., Berkman, B. E., Bombard, Y., Holm, I. A., Levy, H. P., Ormond, K. E., Saal, H. M., Spinner, N. B., et al. (2015) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2015.05.022 · Cited by 898
Placental transport of immunoglobulin G
Simister, N. (2003) · Vaccine · doi:10.1016/s0264-410x(03)00334-7 · Cited by 783
Microarrays and toxicology: The advent of toxicogenomics
Nuwaysir, E. F., Bittner, M., Trent, J., Barrett, J. C., & Afshari, C. A. (1999) · Molecular Carcinogenesis · doi:10.1002/(sici)1098-2744(199903)24:3<153::aid-mc1>3.0.co;2-p · Cited by 666
Finkelman, F. D., Madden, K. B., Morris, S. C., Holmes, J. M., Boiani, N., Katona, I. M., & Maliszewski, C. R. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.3.1235 · Cited by 366
Braun, A., Kwee, L., Labow, M. A., & Alsenz, J. (1997) · Pharmaceutical Research · doi:10.1023/a:1012193326789 · Cited by 298
Challenges and Limitations of Gene Expression Profiling in Mechanistic and Predictive Toxicology
Fielden, M. R., & Zacharewski, T. R. (2001) · Toxicological Sciences · doi:10.1093/toxsci/60.1.6 · Cited by 170
May, L. T., Neta, R., Moldawer, L. L., Kenney, J. S., Patel, K., & Sehgal, P. B. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.6.3225 · Cited by 108
Drug delivery: an odyssey of 100 years
Pillai, O., Dhanikula, A. B., & Panchagnula, R. (2001) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(00)00226-x · Cited by 105
High-throughput screening approaches for investigating drug metabolism and pharmacokinetics
Roberts, S. (2001) · Xenobiotica · doi:10.1080/00498250110060978 · Cited by 104
Cunningham, M. J. (2000) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/s1056-8719(00)00111-8 · Cited by 101
The Impact of Genomics on Drug Discovery
Debouck, C., & Metcalf, B. (2000) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.40.1.193 · Cited by 96
Brown, R. A. (2002) · Experimental Cell Research · doi:10.1006/excr.2002.5471 · Cited by 89
Predictive value of animal studies in toxicology
Zbinden, G. (1991) · Regulatory Toxicology and Pharmacology · doi:10.1016/0273-2300(91)90004-f · Cited by 82
Key challenges for toxicologists in the 21st century
Smith, L. L. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01714-4 · Cited by 70
Td, A., & Tj, H. (1989) · PubMed · Cited by 69
Safety Assessment of Biotechnology-Derived Pharmaceuticals: ICH and Beyond
Serabian, M. A., & Pilaro, A. M. (1999) · Toxicologic Pathology · doi:10.1177/019262339902700106 · Cited by 63
‘Biogenerics’: the off-patent biotech products
Schellekens, H., & Ryff, J. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01967-2 · Cited by 56
Using bioinformatics in gene and drug discovery
Searls, D. B. (2000) · Drug Discovery Today · doi:10.1016/s1359-6446(99)01457-9 · Cited by 56
Burchiel, S. W. (2001) · Toxicological Sciences · doi:10.1093/toxsci/59.2.193 · Cited by 53
Nishijima, I., Nakahata, T., Hirabayashi, Y., Inoue, T., Kurata, H., Miyajima, A., Hayashi, N., Iwakura, Y., Arai, K., & Yokota, T. (1995) · Molecular Biology of the Cell · doi:10.1091/mbc.6.5.497 · Cited by 52
Enhancement of the biologic effects of interleukin-3 in vivo by anti- interleukin-3 antibodies
Jones, A., & Ziltener, H. J. (1993) · Blood · doi:10.1182/blood.v82.4.1133.1133 · Cited by 46
Grucza, R. A., Bradshaw, J. M., F�tterer, K., & Waksman, G. (1999) · Medicinal Research Reviews · doi:10.1002/(sici)1098-1128(199907)19:4<307::aid-med4>3.0.co;2-2 · Cited by 43
Comparative Pharmacodynamics of Keliximab and Clenoliximab in Transgenic Mice Bearing Human CD4
Sharma, A., Davis, C. B., Tobia, L. A. P., Kwok, D. C., Tucci, M. G., Gore, E. R., Herzyk, D. J., & Hart, T. K. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39200-6 · Cited by 42
Safety evaluation of biological and biotechnology-derived medicines
Dayan, A. D. (1995) · Toxicology · doi:10.1016/0300-483x(95)03125-y · Cited by 37
Suitability of Animal Models for Predictive Toxicology: Theoretical and Practical Considerations
Calabrese, E. J. (1984) · Drug Metabolism Reviews · doi:10.3109/03602538409029971 · Cited by 33
Miller, L. L., Korn, E. L., Stevens, D., Janik, J. E., Gause, B. L., Kopp, W. C., Holmlund, J., Curti, B. D., Sznol, M., Smith, J. W., et al. (1999) · Blood · doi:10.1182/blood.v93.10.3250.410k35_3250_3258 · Cited by 25
Issues with Biotechnology Products in Toxicologic Pathology
Terrell, T. G., & Green, J. D. (1994) · Toxicologic Pathology · doi:10.1177/019262339402200212 · Cited by 24
Genotoxicity testing of biotechnology-derived products
Gocke, E., Albertini, S., Brendler‐Schwaab, S., et al. (1999) · Mutation Research/Reviews in Mutation Research · doi:10.1016/s1383-5742(99)00002-2 · Cited by 21
Recent developments in computational proteomics
Maggio, E., & Ramnarayan, K. (2001) · Drug Discovery Today · doi:10.1016/s1359-6446(01)02003-7 · Cited by 20
Immunogenicity of Recombinant Human Interleukin-3
Gunn, H. (1997) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1996.4302 · Cited by 18
Recent developments and perspectives of biotechnology-derived products
Thomas, J. A. (1995) · Toxicology · doi:10.1016/0300-483x(95)03122-v · Cited by 18
Neurologic Tumors in Offspring after Inoculation of Mothers with Killed-Poliovirus Vaccine
von Wussow, P., Freund, M., Dahle, S., Jakschies, D., Poliwode, H., & Deicher, H. (1988) · New England Journal of Medicine · doi:10.1056/nejm198811033191815 · Cited by 17
Watts, T. L., & Fasano, A. (2000) · Biotechnology and Genetic Engineering Reviews · doi:10.1080/02648725.2000.10648001 · Cited by 15
Wang, D., Ohdo, S., Koyanagi, S., Takane, H., Aramaki, H., Yukawa, E., & Higuchi, S. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.1.176-180.2001 · Cited by 15
Essential roles for animal models in understanding human toxicities
Russell, R. W. (1991) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(05)80085-5 · Cited by 14
Mordenti, J. J., Cavagnaro, J. A., & Green, J. D. (1996) · Pharmaceutical Research · doi:10.1023/a:1016002823485 · Cited by 10
Self-citationBiomarkers and surrogacy: relevance to chemoprevention.
Kensler, T. W., Ne, D., Groopman, J. D., et al. (2001) · PubMed · Cited by 8
Cited by
The dawning era of polymer therapeutics
Duncan, R. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1088 · Cited by 3,269
Immunological properties of engineered nanomaterials
Dobrovolskaia, M. A., & McNeil, S. E. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.223 · Cited by 1,823
Applying extracellular vesicles based therapeutics in clinical trials – an ISEV position paper
Lener, T., Gimona, M., Aigner, L., Börger, V., Buzas, E., Camussi, G., Chaput, N., Chatterjee, D., Court, F. A., del Portillo, H. A., et al. (2015) · Journal of Extracellular Vesicles · doi:10.3402/jev.v4.30087 · Cited by 1,491
Role of computer-aided drug design in modern drug discovery
Macalino, S. J. Y., Gosu, V., Hong, S., & Choi, S. (2015) · Archives of Pharmacal Research · doi:10.1007/s12272-015-0640-5 · Cited by 762
Section XXIV. Partition Chromatographs
(2009) · Biotechnology · doi:10.1201/9781420084498-31 · Cited by 590
Metadata
- Authors
- Cavagnaro, J. A.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2002-06
- Volume
- 1
- Issue
- 6
- Pages
- 469-475
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W1516645853
- Cited by
- 340
- References
- 38
- FWCI
- 0.35
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.